Vida Ventures Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Hold |
1,798,163
| – | – | 12.76% | 2 |
|
|
2025
Q1 | $2.63M | Hold |
1,798,163
| – | – | 19.25% | 2 |
|
|
2024
Q4 | $3.83M | Hold |
1,798,163
| – | – | 2.62% | 5 |
|
|
2024
Q3 | $5.03M | Hold |
1,798,163
| – | – | 3.63% | 5 |
|
|
2024
Q2 | $4.19M | Hold |
1,798,163
| – | – | 4.58% | 4 |
|
|
2024
Q1 | $8.04M | Hold |
1,798,163
| – | – | 4.47% | 4 |
|
|
2023
Q4 | $5.77M | Hold |
1,798,163
| – | – | 6.87% | 4 |
|
|
2023
Q3 | $5.7M | Hold |
1,798,163
| – | – | 8.82% | 3 |
|
|
2023
Q2 | $8.94M | Hold |
1,798,163
| – | – | 11.67% | 3 |
|
|
2023
Q1 | $8.88M | Hold |
1,798,163
| – | – | 12.15% | 4 |
|
|
2022
Q4 | $11.3M | Hold |
1,798,163
| – | – | 15.2% | 4 |
|
|
2022
Q3 | $19.4M | Hold |
1,798,163
| – | – | 17.43% | 3 |
|
|
2022
Q2 | $20.5M | Hold |
1,798,163
| – | – | 17.32% | 2 |
|
|
2022
Q1 | $16.4M | Hold |
1,798,163
| – | – | 9.53% | 6 |
|
|
2021
Q4 | $26.8M | Hold |
1,798,163
| – | – | 10.04% | 6 |
|
|
2021
Q3 | $46.2M | Hold |
1,798,163
| – | – | 13.24% | 6 |
|
|
2021
Q2 | $46.9M | Hold |
1,798,163
| – | – | 11.76% | 6 |
|
|
2021
Q1 | $63.5M | Hold |
1,798,163
| – | – | 16.04% | 4 |
|
|
2020
Q4 | $45.4M | Hold |
1,798,163
| – | – | 9.32% | 5 |
|
|
2020
Q3 | $67.8M | Buy |
+1,798,163
| New | +$67.8M | 42.47% | 1 |
|